(Q40396473)

English

Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis

scientific article published on August 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

author name string

Karen E Logan

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Mark A Chambers

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

R Glyn Hewinson

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Philip J Hogarth

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

48-49

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5526-5532

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A selective oleic acid albumin agar medium for the cultivation ofMycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Interleukin-17 family members and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Boosting vaccine for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.07.037

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40396473&oldid=2164975862"